ALCGPSC 149/17 - FY2018 URINALYSIS DRUG TESTING ALLOCATIONS

13 DEC 17

ALCGPSC 149/17
SUBJ: FY2018 URINALYSIS DRUG TESTING ALLOCATIONS
A. Coast Guard Drug and Alcohol Program Manual, COMDTINST M1000.10 (series)
1. The mandatory drug testing requirements for FY18 remain at 65 percent of active
duty/SELRES and 100 percent for new accessions.  Units shall test 25 percent of their
annual quota each quarter.  Note: 25 percent per quarter is determined by the total PAL
for active duty and reserve, times 65 percent, divided by four to determine quarterly
quota.  FY18 urinalysis drug testing allocations are available at
http://www.dcms.uscg.mil/PSD/fs/Drug-Testing-Program/. Compliance with the CG’s
Drug Abuse Program is the responsibility of Commanding Officers IAW Art. 4.A.2.d of
Ref A.
2. Urinalysis coordinators (UC) shall use the DoD web-based Drug Testing Program
(DTP) Lite system, Version 5.4.1.1.  Tripler Army Medical Center (TAMC) has updated
DTP Lite to use 10-digit DoD numbers.  Units with members generated on rosters from
DA will need to manually enter their DoD numbers into the roster. 
3.  Until further notice, memos requesting Full Panel Testing are no longer required when
submitting samples to TAMC.
4.   IAW Art. 4.B.1 of Ref A and the FORCECOM Admin Assessment Checklist, units
shall retain urinalysis testing paperwork for the current year plus one additional year, 
including: 1) copies of the DD-Form 2624, Urinalysis Ledger, 2) mail receipt showing
date samples were shipped, and 3) corresponding results from TAMC for each testing
event.
5.  Units receiving positive urinalysis results must report those results to the Coast Guard
Investigative Service (CGIS) for entry into National Instant Criminal Background Check
System (NICS).  Upon being notified of a positive urinalysis result, CGIS will work with
the command to determine if a CGIS investigation is warranted versus a unit
investigation outlined in Chap. 3 of Ref A.  Units shall notify CG PSC PSD-FS of all
positive urinalysis result outcomes. In addition, Ref A, Art. 3.B.4.a.(2) requires units to
document and report findings of “No Drug Incidents” to CG PSC PSD-FS. 
6.  Discrepancy rates continue to be exceedingly high. Discrepancy codes by unit are
included in monthly reports from TAMC and provided to Major Commands
(MAJCOMs) by CG PSC PSD-FS. The most common discrepancies continue to be (FA):
The UIC or BAC in blocks 4 or 3 is either incorrect or doesn't match that found on the
bottle label; (FN): The most common reason is the absence of a single original signature
on the custody section; (GG): If the collector includes a bottle as space filler (helps keep
the bottle from moving in shipment yielding illegible labels and/or spills) it must have no
label. The form should have a line through the SSN with the collector's initials and date. 
MAJCOMS and units are encouraged to closely review monthly drug testing reports to
ensure specimens are processed IAW Ref A and to proactively address reported
discrepancies, especially those leading to rejected samples.  These errors can be remedied
by utilizing DTP Lite, paying attention to detail and utilizing the Urinalysis Tactics,
Techniques and Procedures (TTP) provided on the DCMS Drug Testing website in
paragraph 1 above.
7. For general urinalysis questions, units should contact their MAJCOM coordinator.  CG
PSC PSD-FS POC is CWO Eric Lowe, (202) 795-6646, email eric.p.lowe(at)uscg.mil.
8. RDML M. T. Bell Jr., Commander, CG Personnel Service Center, sends. The Service
Center for Our Most Important Resource – Our People.
9. Internet release authorized.